Indeed, some researchers reported that the suppression of FABP4 diminished the ability of an enhanced 5-hydroxymethylcytosine formation in DNA to invade the high-lipid cancer milieu, leading to decreased expression of genes involved in OC dissemination and enhanced susceptibility to chemotherapy both in vitro and in vivo. Here, FABP4 is linked to cancer.